Read + Share
Colak Y, Hasan B, Erkalma B, Tandon K, et al. Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the
inflammasome as a new therapeutic target. Clin Res Hepatol Gastroenterol 2021;45:101710.
PMID: 33930586
|
 |
|
Colak Y, Hasan B, Erkalma B, Tandon K, et al. Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the
inflammasome as a new therapeutic target. Clin Res Hepatol Gastroenterol 2021;45:101710.
PMID: 33930586
|
|
|
|